Literature DB >> 31350568

Adverse Perioperative Events in Children with Complex Congenital Heart Disease Undergoing Operative Scoliosis Repair in the Contemporary Era.

Robert Przybylski1, Daniel J Hedequist2, Viviane G Nasr3, Mary Ellen McCann4, Robert M Brustowicz4, John B Emans2, Audrey C Marshall5, David W Brown5.   

Abstract

Scoliosis is common in children with congenital heart disease (CHD) and may have deleterious effects on quality of life and hemodynamics. Relatively little is known about the outcomes of spinal fusion for scoliosis repair in children with complex CHD. We reviewed all cases of children with CHD undergoing first time spinal fusion excluding those with minor CHD between 1995 and 2015. Seventy-eight patients were identified and included in the study. 97.4% of patients included had undergone prior cardiac surgery and sixteen patients had single ventricle circulations. 17.9% of patients experienced a significant perioperative event defined as an aggregate of the presence of any of the following: need for early unanticipated reoperation, neurologic deficit, postoperative bleeding requiring intervention, end organ dysfunction, or death. There were no deaths in our cohort. 38.5% of patients experienced any adverse event, the majority of which were related to perioperative fluid shifts. Larger preoperative Cobb angle and longer length of spinal fusion were associated with increased risk of significant perioperative event while larger preoperative Cobb angle and longer length of spinal fusion, older age at time of surgery, single ventricle circulation, cyanosis and patients taking cardiac medications at the time of surgery were more likely to experience any adverse event. Operative repair of scoliosis in children with complex CHD has been performed without mortality over a 20-year period in a single institution, albeit with a higher rate of perioperative complication than is seen in the general pediatric population. Patients with large preoperative Cobb angles and cyanotic single ventricle circulations appear to be at the highest risk for perioperative complications.

Entities:  

Keywords:  Congenital heart disease; Scoliosis; Spinal fusion

Mesh:

Year:  2019        PMID: 31350568     DOI: 10.1007/s00246-019-02169-1

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  24 in total

1.  Operative treatment of scoliosis in patients with a Fontan circulation.

Authors:  Daniel J Hedequist; John B Emans; John E Hall
Journal:  Spine (Phila Pa 1976)       Date:  2006-01-15       Impact factor: 3.468

Review 2.  What impact does spinal deformity correction for adolescent idiopathic scoliosis make on quality of life?

Authors:  Aina J Danielsson
Journal:  Spine (Phila Pa 1976)       Date:  2007-09-01       Impact factor: 3.468

3.  Spinal fusion in patients with congenital heart disease. Predictors of outcome.

Authors:  D L Coran; W B Rodgers; J F Keane; J E Hall; J B Emans
Journal:  Clin Orthop Relat Res       Date:  1999-07       Impact factor: 4.176

4.  Complications in spinal fusion for adolescent idiopathic scoliosis in the new millennium. A report of the Scoliosis Research Society Morbidity and Mortality Committee.

Authors:  Jeffrey D Coe; Vincent Arlet; William Donaldson; Sigurd Berven; Darrell S Hanson; Ram Mudiyam; Joseph H Perra; Christopher I Shaffrey
Journal:  Spine (Phila Pa 1976)       Date:  2006-02-01       Impact factor: 3.468

5.  Development and Validation of a Risk Stratification Score for Children With Congenital Heart Disease Undergoing Noncardiac Surgery.

Authors:  David Faraoni; Daniel Vo; Viviane G Nasr; James A DiNardo
Journal:  Anesth Analg       Date:  2016-10       Impact factor: 5.108

6.  [Long-term results of quality of life in patients with idiopathic scoliosis after Harrington instrumentation and their relevance for expert evidence].

Authors:  C Götze; A Slomka; H G Götze; W Pötzl; U Liljenqvist; J Steinbeck
Journal:  Z Orthop Ihre Grenzgeb       Date:  2002 Sep-Oct

Review 7.  Outcomes after the Fontan procedure.

Authors:  Bradley S Marino
Journal:  Curr Opin Pediatr       Date:  2002-10       Impact factor: 2.856

8.  Scoliosis and congenital heart disease.

Authors:  N Kawakami; K Mimatsu; M Deguchi; F Kato; S Maki
Journal:  Spine (Phila Pa 1976)       Date:  1995-06-01       Impact factor: 3.468

9.  Scoliosis surgery in children with congenital heart disease.

Authors:  Muayad Kadhim; Ellen Spurrier; Deepika Thacker; Christian Pizarro; William G Mackenzie
Journal:  Spine (Phila Pa 1976)       Date:  2014-02-01       Impact factor: 3.468

10.  Congenital spinal deformity: a comprehensive assessment at presentation.

Authors:  Partha S Basu; Hazem Elsebaie; M H H Noordeen
Journal:  Spine (Phila Pa 1976)       Date:  2002-10-15       Impact factor: 3.468

View more
  4 in total

1.  Conservative treatment of a scoliosis patient after two heart surgeries in early childhood - A case report.

Authors:  Hans-Rudolf Weiss; Manuel Lay; Tamisha Best-Gittens; Marc Moramarco; Mario Jimeranez
Journal:  S Afr J Physiother       Date:  2021-11-30

2.  Perioperative Management of an Adolescent Fontan Patient with Narrowing of the Aortopulmonary Space for Posterior Scoliosis Surgery.

Authors:  Kim van Loon; Remco Minkhorst; Henriette Ter Heide; Hans M P Breur; Moyo C Kruyt; Tom P C Schlosser
Journal:  Semin Cardiothorac Vasc Anesth       Date:  2022-08-11

3.  Cancer diagnostic profile in children with structural birth defects: An assessment in 15,000 childhood cancer cases.

Authors:  Jeremy M Schraw; Tania A Desrosiers; Wendy N Nembhard; Peter H Langlois; Robert E Meyer; Mark A Canfield; Sonja A Rasmussen; Tiffany M Chambers; Logan G Spector; Sharon E Plon; Philip J Lupo
Journal:  Cancer       Date:  2020-05-29       Impact factor: 6.860

4.  Management of Severe Scoliosis with Pulmonary Arterial Hypertension: A Single-Center Retrospective Case Series Study.

Authors:  Qiang Li; Fei Zeng; Tao Chen; Mengqiu Liang; Xue Lei; Yijian Liang; Chuandong Zheng; He Huang
Journal:  Geriatr Orthop Surg Rehabil       Date:  2022-03-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.